BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1629013)

  • 1. Labelling of leukocytes with 99mTc-HMPAO for scintigraphy of inflammatory lesions and abscesses.
    Vanlić-Razumenić N; Pujić N; Dedović N; Kostić K; Nastić-Mirić D
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):251-6. PubMed ID: 1629013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
    Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
    Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucocytes labelled with 99mTc-HMPAO in the detection of abdominal abscesses.
    Lantto EH
    Eur J Surg; 1991 Aug; 157(8):469-72. PubMed ID: 1681934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedure for red blood cell labelling with 99mTc-HMPAO. Methodology and quality control.
    Bassa P; García Garzón JR; Piera C; Pavía A; Minoves M; Moragas M; Pavía J; Lomeña F; Setoain J
    Nucl Med Biol; 1994 Oct; 21(7):963-7. PubMed ID: 9234351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
    Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-efficiency, rapid and multi-dose procedure for white blood cell labelling with 99Tcm-HMPAO.
    Ozker K; Collier BD; Hellman RS; Isitman AT; Krasnow AZ; Uzum F; Steffel FS
    Nucl Med Commun; 1996 Apr; 17(4):342-5. PubMed ID: 8786871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging inflammation with 99Tcm HMPAO labelled leucocytes.
    Reynolds JH; Graham D; Smith FW
    Clin Radiol; 1990 Sep; 42(3):195-8. PubMed ID: 2208930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods.
    Mansfield JC; Giaffer MH; Tindale WB; Holdsworth CD
    Gut; 1995 Nov; 37(5):679-83. PubMed ID: 8549945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of inflammation with 99mTC-HMPAO labelled leucocytes.
    Paakkinen S; Vorne M; Lantto T; Mokka R; Sakki S
    Ann Chir Gynaecol; 1987; 76(4):197-200. PubMed ID: 3481240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukocyte scintigraphy: clinical application to inflammatory diseases and bone marrow diseases].
    Miyazaki C
    Kaku Igaku; 1995 Jul; 32(7):703-7. PubMed ID: 7674583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.
    Mang'era KO; Vanbilloen HP; Schiepers CW; Verbruggen AM
    Eur J Nucl Med; 1995 Oct; 22(10):1163-72. PubMed ID: 8542901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
    Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
    Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease.
    Giaffer MH; Tindale WB; Holdsworth D
    Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast diagnosis of abdominal infections and inflammations with technetium-99m-HMPAO labeled leukocytes.
    Lantto EH; Lantto TJ; Vorne M
    J Nucl Med; 1991 Nov; 32(11):2029-34. PubMed ID: 1941134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Cell Fraction of
    Kim EM; Jeong HJ; Lim ST; Sohn MH
    Curr Radiopharm; 2020; 13(2):142-148. PubMed ID: 32386504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.
    Ecclestone M; Proulx A; Ballinger JR; Gerson B; Reid RH; Gulenchyn KY
    Eur J Nucl Med; 1990; 16(4-6):299-302. PubMed ID: 2161770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease.
    Alonso JC; Lopez-Longo FJ; Lampreave JL; González CM; Vegazo O; Carreño L; Almoguera I
    Eur J Nucl Med; 1996 Mar; 23(3):243-6. PubMed ID: 8599954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabelling of human platelets with 99mTc-HMPAO.
    Vorne M; Honkanen T; Karppinen K; Röning M; Sakki S
    Eur J Haematol; 1989 May; 42(5):487-91. PubMed ID: 2731595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of abdominal inflammation using other radioisotope techniques.
    Vorne M
    Scand J Gastroenterol Suppl; 1994; 203():48-54. PubMed ID: 7973449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.